Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Glimepiride I.P. 1mg + Voglibose I.P. 0.3mg + Metformin HCL I.P. 500mg Bi-Layered Tablets
Therapeutic Category
Antidiabetic, Diabetic, Endocrinology
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10*15
Price
₹189/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Vogliviga GM1/0.3 Tablet contains Glimepiride 1mg, Voglibose 0.3mg, and Metformin 500mg in a bi-layered formulation to effectively manage type 2 diabetes mellitus. Glimepiride promotes insulin secretion, Voglibose helps reduce post-meal blood sugar spikes by slowing carbohydrate absorption, and Metformin improves insulin sensitivity while decreasing hepatic glucose production. This combination ensures comprehensive blood sugar control throughout the day.
Possible side effects include nausea, abdominal discomfort, bloating, diarrhea, and risk of hypoglycemia. Long-term use may lead to vitamin B12 deficiency. Patients should monitor blood glucose regularly.
It is prescribed for the treatment of type 2 diabetes, particularly for patients needing control of both fasting and postprandial glucose levels.
Not recommended for patients with type 1 diabetes, severe kidney or liver impairment, or diabetic ketoacidosis. Alcohol should be avoided during treatment. Follow medical advice strictly and report any unusual symptoms.
Store in a cool, dry place below 25°C, away from direct sunlight and moisture. Keep out of reach of children.
Composition : Metformin (500mg) SR + Voglibose (0.3mg) Tablet
Composition : Metformin (500mg) SR + Voglibose (0.2mg) Bilayered Smart Tablet
Composition : Glimepiride (2mg) + Metformin (500mg) SR + Voglibose (0.2mg) Bilayered Smart Tablet
Composition : Rosuvastatin 10 mg tablet
Composition : Rosuvastatin (20mg) tablet
Composition : Rosuvastatin 40 mg tablet
Composition : Rosuvastatin 5mg + fenofibrate 160 mg tablet
Composition : Rosuvastatin 20 mg + aspirin 75 mg tablet
Composition : Atorvastatin Calcium I.P. 10mg Tablets
Composition : Atorvastatin Calcium I.P. 20mg Tablets
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This triple anti-diabetic combination is used for advanced type 2 diabetes management, making it a strong prescription product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand in type 2 diabetes, post-meal blood sugar control, insulin resistance, and long-term glycemic management in patients requiring multi-drug therapy. It is widely prescribed by physicians and diabetologists for better glucose control throughout the day.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Glimepiride 1mg + Voglibose 3mg + Metformin HCl Layered Tablets with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from strong chronic prescription demand, lifelong therapy cycles, and steady monthly repeat sales in diabetes care when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this diabetic formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.